Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 20 and 70 years old
- People whose blood pressure, measured at a clinic, shows a top number (systolic) of 150 or higher but below 180, and a bottom number (diastolic) of 90 or higher
- People who are currently prescribed one, two, or three different types of blood pressure-lowering medications
- People whose average blood pressure over a 24-hour monitoring period shows a top number of 135 or higher but below 170 (measured at the start of the trial)
Who may not be able to join:
- People who have previously had a procedure called renal denervation (a treatment targeting nerves near the kidneys)
- People whose kidney arteries are not shaped or structured in a way that is suitable for the trial procedure
- People who have a stent (a small tube) placed in a kidney artery
- People whose kidneys are not filtering blood well enough, based on a specific kidney function measurement called eGFR being below 60 (confirm with trial site)
- People who are currently taking a type of medication known as SGLT2 inhibitors or GLP-1 agonists (commonly used for diabetes or weight management)
- People who need ongoing oxygen support or a breathing machine to help them breathe
- People diagnosed with primary pulmonary hypertension (high blood pressure specifically affecting the lungs)
- People whose high blood pressure is caused by another underlying medical condition
- People who are pregnant, breastfeeding, or planning to become pregnant during the study
- People who have a condition that would make it difficult to get an accurate blood pressure reading
- People who are currently taking a type of medication called anti-mineralocorticoids (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +31 6 1113 5502
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All-cause mortality; End-stage renal disease; Myocardial infarction; Incidence of stroke; Hospitalization for hypertensive crisis not related to non-adherence with medications; Significant embolic event resulting in end-organ damage; Renal artery intervention; New renal artery stenosis >70%, confirmed by angiography and as determined by the angiographic core lab; Vascular complications; Major bleeding according to TIMI definition; Prolonged renal vasoconstriction requiring intervention; Contrast induced nephropathy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.